OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
Britt Hanson, Sofia Stenler, Nina Ahlskog, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 30, pp. 379-397
Open Access | Times Cited: 11

Showing 11 citing articles:

Therapeutic approaches for Duchenne muscular dystrophy
Thomas C. Roberts, Matthew J. A. Wood, Kay E. Davies
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 11, pp. 917-934
Closed Access | Times Cited: 60

CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10

CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
Francesco Chemello, Eric N. Olson, Rhonda Bassel‐Duby
Human Gene Therapy (2023) Vol. 34, Iss. 9-10, pp. 379-387
Open Access | Times Cited: 18

Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs
Antonio Garcia-Guerra, Chaitra Sathyaprakash, Olivier G. de Jong, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 2
Open Access

Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy
Katarzyna Chwalenia, Matthew J. A. Wood, Thomas C. Roberts
Journal of Muscle Research and Cell Motility (2025)
Open Access

Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review
Sylwia Szwec, Zuzanna Kapłucha, Jeffrey S. Chamberlain, et al.
BioDrugs (2023) Vol. 38, Iss. 1, pp. 95-119
Open Access | Times Cited: 9

Myospreader improves gene editing in skeletal muscle by myonuclear propagation
Kiril Poukalov, M. Carmen Valero, Derek R. Muscato, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 19
Open Access | Times Cited: 3

Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
Katarzyna Chwalenia, Jacopo Oieni, Joanna Zemła, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 955-968
Open Access | Times Cited: 8

Myospreader improves gene editing in skeletal muscle by myonuclear propagation
Kiril Poukalov, M. Carmen Valero, Derek R. Muscato, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs
Antonio Garcia-Guerra, Chaitra Sathyaprakash, Olivier G. de Jong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top